Siemens Healthineers Debuts RT Pro Edition for Magnetom Sola

At the 60th annual meeting of the A merican Society for Radiation Oncology (ASTRO), Oct. 21-24 at the Henry B. Gonzalez Convention Center in San Antonio, Siemens Healthineers unveiled the Magnetom RT Pro edition for Magnetom Sola – a version of the company’s new 1.5 Tesla (1.5T) magnetic resonance imaging (MRI) scanner that is designed for assistance in radiation therapy (RT) treatment planning. In addition to BioMatrix technology, which addresses patients’ anatomical and physiological differences to overcome unwanted exam variability, the new scanner includes hardware and software that supports optimal treatment planning.

The Magnetom RT Pro edition for Magnetom Sola has an all-new magnet as well as a system architecture designed for extremely high performance and long-term stability. The RT Dot engine predefines RT strategies, automatically corrects for image distortion to improve spatial integrity, and automatically reconstructs axial images to enable direct processing of all data in RT planning software. It also offers an interface with RT positioning lasers to support accurate patient positioning.

The scanner’s new, dedicated RT post-planning software, RT Image Suite, permits the calculation of synthetic computed tomography (CT) images derived from MR images. These synthetic CT images provide essential information for patients with brain and prostate tumors that typically had been acquired with CT, eliminating the need for patients to lie on the treatment bed for two separate imaging sessions. RT Image Suite is also new to the RT Pro Edition for Magnetom Vida, the 3T scanner for assistance in RT planning that debuted at ASTRO 2017.

Additionally, Resolve software reduces distortions associated with MR diffusion imaging by a factor of three, enabling the use of these images in the dose planning process for the linear accelerator.

“With the introduction of the Magnetom RT Pro edition for Magnetom Sola, Siemens Healthineers once again raises the bar in the development of MRI scanners for assistance in radiation therapy planning, with features such as RT Image Suite that expand precision medicine and improve the overall patient experience,” said Hanno Dotzel, Vice President of Radiation Oncology at Siemens Healthineers North America.

For more information: www.usa.healthcare.siemens.com

Related Content

Early diagnosis of cancer is one of the highest-priority problem for the healthcare system, because it is critical for overall treatment success and saving patients' lives. Diffusion-weighted magnetic resonance imaging (DWI) may be used to detect a malignancy in various tissues and organs. It has the advantage of providing insight into the diffusion of water molecules in body tissues without exposing patients to radiation.

DWI of the phantom with polyvinylpyrrolidone (PVP) solutions (b value 500 s/mm2). Image courtesy of Kristina Sergunova et al.

News | Magnetic Resonance Imaging (MRI) | June 02, 2020

MRI Technique Developed to Improve Detection of Tumors

June 2, 2020 — Early diagnosis of cancer is one of the highest-priority problem for the healthcare system, because it

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire)

AIR Recon DL delivers shorter scans and better image quality (Photo: Business Wire).

News | Artificial Intelligence | May 29, 2020

Deep Learning-Based MR Image Reconstruction Tech From GE Healthcare Now FDA Cleared

May 29, 2020 — GE Healthcare announced U.S.

United Imaging's uMR OMEGA is designed to provide greater access to magnetic resonance imaging (MRI) with the world’s first ultra-wide 75-cm bore 3T MRI.

News | Magnetic Resonance Imaging (MRI) | May 27, 2020

United Imaging Debuts Ultra-wide 75 cm Bore 3T MRI

May 27, 2020 — United Imaging's...

A new technique developed by researchers at UC Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The team created a probe that generates two magnetic resonance signals that suppress each other until they reach the target, at which point they both increase contrast between the tumor and surrounding tissue

A new technique developed by researchers at UC Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The team created a probe that generates two magnetic resonance signals that suppress each other until they reach the target, at which point they both increase contrast between the tumor and surrounding tissue. Image courtesy of Xiandoing Xue, UC Davis

News | Magnetic Resonance Imaging (MRI) | May 26, 2020

New Double-contrast Technique Picks Up Small Tumors on MRI

May 26, 2020 — Researchers at the University of California, Davis offers a...

Researchers from Tokyo Metropolitan University have surveyed the amount of gadolinium found in river water in Tokyo. Gadolinium is contained in contrast agents given to patients undergoing medical magnetic resonance imaging (MRI) scans, and it has been shown in labs to become toxic when exposed to ultraviolet rays. The researchers found significantly elevated levels, particularly near water treatment plants, highlighting the need for new public policy and removal technologies as MRI become even more commonp

Samples were taken along rivers around Tokyo. Measurements of rare earth element quantities indicate a clearly elevated amount of gadolinium compared to that in natural shale. Graphics courtesy of Tokyo Metropolitan University

News | Magnetic Resonance Imaging (MRI) | May 26, 2020

MRI's Environmental Impact

May 26, 2020 — Researchers from Tokyo Metropolitan...

Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients, according to a new national survey from the American Society for Radiation Oncology (ASTRO).

Getty Images

News | Coronavirus (COVID-19) | May 21, 2020

ASTRO Survey Finds Fewer Patient Visits Despite Enhanced COVID-19 Safety Measures

May 21, 2020 — Despite facing challenges such as limited access to...

Advanced imaging data exchange is now live in Colorado due to the partnership of Health Images and the Colorado Regional Health Information Organization

Getty Images

News | Radiology Business | May 18, 2020

Colorado Providers Now Have Access to Medical Images via HIE

May 18, 2020 —

Experimental Protocol and Representative MRI of Brains at Various Key Points in That Protocol.

Experimental Protocol and Representative MRI of Brains at Various Key Points in That Protocol. (A) Experimental timeline. (B) Representative T2WI (using an 11.7T MRI) of the brain of a postnatal day (PND) 11 pup, 1 day after inducing left HII and prior to hNSC transplantation. Note the beginning of an increasingly intense “water signal” (white) on the left (“HII lesion”). (C) Representative T2WI (using an 11.7T MRI) 3 days post-HII, shortly after implantation of SPIO pre-labeled hNSCs into the contralateral cerebral ventricle (“Lateral Vent”). Note the “HII lesion” on the left becoming hyperintense (white) and the black signal void of the SPIO-labeled hNSCs in the lateral ventricle (black arrow). Red arrows denote the needle track. In contrast to what occurs in the intact brain (Figure S4), in a brain subjected to left HII, the implanted SPIO-labeled hNSCs (black signal void) (black arrow) migrate from the right (“R”) to the left (“L”) hemisphere to enter the lesion. (D and E) Shown here (using a 4.7T MRI) are SPIO-labeled hNSCs (black signal void) (black arrow) at 1 month post-implantation into the contralateral ventricle (D) and, in the same representative animal, at 3 months post-implantation (E)–stably integrated and surrounding a much-reduced residual lesion, with no interval enlargement of the graft or ventricles.

News | Magnetic Resonance Imaging (MRI) | May 13, 2020

Scientists Show MRI Predicts the Efficacy of a Stem Cell Therapy for Brain Injury

May 13, 2020 — Scientists at Sanford Burnham Prebys Medical Discov...

Axial (A) and coronal (B) CT of the abdomen and pelvis with IV contrast in a 57-year-old man with a high clinical suspicion for bowel ischemia. There was generalized small bowel distension and segmental thickening (arrows), with adjacent mesenteric congestion (thin arrow in B), and a small volume of ascites (* in B). Findings are nonspecific but suggestive of early ischemia or infection.

Axial (A) and coronal (B) CT of the abdomen and pelvis with IV contrast in a 57-year-old man with a high clinical suspicion for bowel ischemia. There was generalized small bowel distension and segmental thickening (arrows), with adjacent mesenteric congestion (thin arrow in B), and a small volume of ascites (* in B). Findings are nonspecific but suggestive of early ischemia or infection. Image courtesy of RSNA

News | Coronavirus (COVID-19) | May 11, 2020

Imaging Reveals Bowel Abnormalities in Patients with COVID-19

May 11, 2020 — Patients with COVID-19 can have b

Whole body diffusion-weighted magnetic resonance imaging (DW MRI) may aid in the assessment of cancer treatment response in children and youth at much lower levels of radiation than current approaches, suggests a small study funded by the National Institutes of Health.

News | Pediatric Imaging | May 05, 2020

MRI Technique Could Reduce Need for Radiation in Measuring Tumor Response to Chemotherapy

May 5, 2020 — Whole body diffusion-weighted magnetic resonance imaging (DW MRI) may aid in the assessment of...